Shares Outstanding Shares Outstanding n/a Close	1.08M
Shares Change (YoY) Shares Change (YoY) n/a Close	64.87%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	10.26%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	2.89%
Shares Floating Shares Floating n/a Close	979.57K
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	6
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.03%

Short Selling Information

The latest short interest is 29.6K, so 2.74% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	29.6K
Short % of Shares Out Short % of Shares Out n/a Close	2.74%
Short % of Float Short % of Float n/a Close	2.76%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	1

Valuation Ratios

The PE ratio is -0.49 and the forward PE ratio is -0.49. Heart Test Laboratories's PEG ratio is 0.

PE Ratio PE Ratio n/a Close	-0.49
Forward PE Forward PE n/a Close	-0.49
PS Ratio PS Ratio n/a Close	175.12
Forward PS Forward PS n/a Close	0.7
PB Ratio PB Ratio n/a Close	0.45
P/FCF Ratio P/FCF Ratio n/a Close	-0.53
PEG Ratio PEG Ratio n/a Close	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Heart Test Laboratories.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 4.2, with a Debt / Equity ratio of 0.14.

Current Ratio Current Ratio n/a Close	4.2
Quick Ratio Quick Ratio n/a Close	3.84
Debt / Equity Debt / Equity n/a Close	0.14
Debt / EBITDA Debt / EBITDA n/a Close	-0.17
Debt / FCF Debt / FCF n/a Close	-0.17
Interest Coverage Interest Coverage n/a Close	-17.81

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$1,240
Profits Per Employee Profits Per Employee n/a Close	$-440,347.2
Employee Count Employee Count n/a Close	15
Asset Turnover Asset Turnover n/a Close	0
Inventory Turnover Inventory Turnover n/a Close	0.01

Taxes

Income Tax Income Tax n/a Close	n/a
Effective Tax Rate Effective Tax Rate n/a Close	0%

Stock Price Statistics

The stock price has increased by -33.64% in the last 52 weeks. The beta is 2.58, so Heart Test Laboratories's price volatility has been higher than the market average.

Beta Beta n/a Close	2.58
52-Week Price Change 52-Week Price Change n/a Close	-33.64%
50-Day Moving Average 50-Day Moving Average n/a Close	3.47
200-Day Moving Average 200-Day Moving Average n/a Close	3.4
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	48.77
Average Volume (20 Days) Average Volume (20 Days) n/a Close	23,842

Income Statement

In the last 12 months, Heart Test Laboratories had revenue of 18.6K and earned -6.61M in profits. Earnings per share was -18.74.

Revenue Revenue n/a Close	18.6K
Gross Profit Gross Profit n/a Close	12.52K
Operating Income Operating Income n/a Close	-6.31M
Net Income Net Income n/a Close	-6.61M
EBITDA EBITDA n/a Close	-6.16M
EBIT EBIT n/a Close	-6.25M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-18.74

Full Income Statement

Balance Sheet

The company has 5.81M in cash and 1.04M in debt, giving a net cash position of 4.77M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	5.81M
Total Debt Total Debt n/a Close	1.04M
Net Cash Net Cash n/a Close	4.77M
Retained Earnings Retained Earnings n/a Close	-67.36M
Total Assets Total Assets n/a Close	5.7M
Working Capital Working Capital n/a Close	-77.64K

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.07M and capital expenditures -125.27K, giving a free cash flow of -6.2M.

Operating Cash Flow Operating Cash Flow n/a Close	-6.07M
Capital Expenditures Capital Expenditures n/a Close	-125.27K
Free Cash Flow Free Cash Flow n/a Close	-6.2M
FCF Per Share FCF Per Share n/a Close	-17.57

Full Cash Flow Statement

Margins

Gross margin is 67.31%, with operating and profit margins of -33901.99% and -35511.87%.

Gross Margin Gross Margin n/a Close	67.31%
Operating Margin Operating Margin n/a Close	-33901.99%
Pretax Margin Pretax Margin n/a Close	-35511.87%
Profit Margin Profit Margin n/a Close	-35511.87%
EBITDA Margin EBITDA Margin n/a Close	-33096.75%
EBIT Margin EBIT Margin n/a Close	-33901.99%
FCF Margin FCF Margin n/a Close	-33308.9%

Dividends & Yields

HSCS does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for HSCS is $14, which is 292.2% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$14
Price Target Difference Price Target Difference n/a Close	292.2%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	3

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on May 17, 2024. It was a backward split with a ratio of 1:100.

Last Split Date Last Split Date n/a Close	May 17, 2024
Split Type Split Type n/a Close	backward
Split Ratio Split Ratio n/a Close	1:100

Scores

Altman Z-Score Altman Z-Score n/a Close	-19546.19
Piotroski F-Score Piotroski F-Score n/a Close	0